ePrivacy and GPDR Cookie Consent by TermsFeed Generator

DOXORUBICIN EBEWE

2MG/ML INF CNC SOL 1X5ML

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 04.09.2020
Interruption of marketing 27.07.2020 0107681, 0139063, 0139065, 0139066
Capacity/distribution reasons 36. týden
Resumption of marketing 08.04.2020
Interruption of marketing 06.04.2020 0107681, 0139063, 0139065, 0139066
Capacity/distribution reasons 17. týden
Resumption of marketing 09.10.2019
Interruption of marketing 11.09.2019 0107681, 0139063, 0139066
Capacity/distribution reasons 39. týden
Resumption of marketing 07.05.2019
Interruption of marketing 29.04.2019 0107681, 0139063, 0139065, 0139066
Capacity/distribution reasons 20. týden
Resumption of marketing 16.01.2017
Interruption of marketing 12.01.2017 0139063, 0139065, 0139066
Resumption of marketing 11.08.2014
Interruption of marketing 20.09.2011 0107681
Placing on the market 01.02.2008
Resumption of marketing 01.09.2011
Interruption of marketing 02.08.2011 lék v jiné lékové formě

All reports are available in the Overview.

Back to list